References
- 250, D. m. ICD-9data.com. http://www.icd9data.com/2014/Volume1/240-279/249-259/250/default.htm
- Andes, L. J., Li, Y., Srinivasan, M., Benoit, S. R., Gregg, E., & Rolka, D. B. (2019). Diabetes prevalence and incidence among Medicare beneficiaries – United States, 2001–2015. MMWR. Morbidity and Mortality Weekly Report, 68(43), 961–966. https://doi.org/10.15585/mmwr.mm6843a2
- Centers for Disease Control and Prevention. Official authorized addenda: Human immunodeficiency virus infection codes and official guidelines for coding and reporting ICD-9-CM. https://wonder.cdc.gov/wonder/prevguid/m0032908/m0032908.asp
- Centers for Disease Control and Prevention. (2018). Diabetes report card 2017. https://www.cdc.gov/diabetes/pdfs/library/diabetesreportcard2017-508.pdf
- Control, C. f. D., Control, P. J. A. C. f. D., Prevention, U. D. o. H., & Services, H. (2020). National diabetes statistics report, 2020.
- Cowell, A., Shenoi, S. V., Kyriakides, T. C., Friedland, G., & Barakat, L. A. (2015). Trends in hospital deaths among human immunodeficiency virus-infected patients during the antiretroviral therapy era, 1995 to 2011. Journal of Hospital Medicine, 10(9), 608–614. https://doi.org/10.1002/jhm.2409
- Dunn, A., Grosse, S. D., & Zuvekas, S. H. (2018). Adjusting health expenditures for inflation: A review of measures for health services research in the United States. Health Services Research, 53(1), 175–196. https://doi.org/10.1111/1475-6773.12612
- Glantz, N. M., Duncan, I., Ahmed, T., Fan, L., Reed, B. L., Kalirai, S., & Kerr, D. (2019). Racial and ethnic disparities in the burden and cost of diabetes for U.S. Medicare beneficiaries. Health Equity, 3(1), 211–218. https://doi.org/10.1089/heq.2019.0004
- Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., & Stefaniak, M. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS (London, England), 18(Suppl 1), S19–S25. https://doi.org/10.1097/00002030-200418001-00004
- ICDdata.com. (2018a). Chronic viral hepatitis B with delta-agent. https://www.icd10data.com/ICD10CM/Codes/A00-B99/B15-B19/B18-/B18.1
- ICDdata.com. (2018b). Chronic viral hepatitis C. https://www.icd10data.com/ICD10CM/Codes/A00-B99/B15-B19/B18-/B18.2
- Ngo-Metzger, Q., Mabry-Hernandez, I., Heslin, K., Weiss, A., Mummert, A., & Bierman, A. (2006). Characteristics of inpatient stays involving hepatitis C, 2005–2014: Statistical Brief# 232.
- Organization, W. H. (2006). Certain infectious and parasitic diseases: ICD Version 2007. http://apps.who.int/classifications/apps/icd/icd10online2007/index.htm?gb20.htm+
- Pumkam, C., Probst, J. C., Bennett, K. J., Hardin, J., & Xirasagar, S. (2013). Health care expenditures among working-age adults with physical disabilities: Variations by disability spans. Disability and Health Journal, 6(4), 287–296. https://doi.org/10.1016/j.dhjo.2013.03.002
- ResDAC. (2020). Research identifiable file availability. https://www.resdac.org/file-availability
- ResDAC. (Barbara Frank). Definitions of “cost” in Medicare utilization files. file:///C:/Users/Ericdon/Downloads/Definitions20of20'Cost'20in20Medicare20Utilization20Files20(Slides)20(1).pdf
- Samaras, K., Wand, H., Law, M., Emery, S., Cooper, D., & Carr, A. (2007). Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International diabetes Foundation and Adult Treatment Panel III criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Diabetes Care, 30(1), 113–119. https://doi.org/10.2337/dc06-1075
- Using Appropriate Price Indices for Analyses of Health Care Expenditures or Income Across Multiple Years. (2020). https://meps.ahrq.gov/about_meps/Price_Index.shtml
- Zingmond, D. S., Arfer, K. B., Gildner, J. L., & Leibowitz, A. A. (2017). The cost of comorbidities in treatment for HIV/AIDS in California. PloS one, 12(12), e0189392. https://doi.org/10.1371/journal.pone.0189392